LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer

References

• Vaughan S, Coward JI, Bast RC, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719–725. doi:10.1038/nrc314421941283
   PubMed Web of Science ®Google Scholar
• Vargas-Hernández VM, Moreno-Eutimio MA, Acosta-Altamirano G, Vargas-Aguilar VM. Management of recurrent epithelial ovarian cancer. Gland Surg. 2014;3(3):198–202. doi:10.3978/j.issn.2227-684X.2013.10.0125207212
   PubMedGoogle Scholar
• Atkinson SR, Marguerat S, Bahler J. Exploring long non-coding RNAs through sequencing. Semin Cell Dev Biol. 2012;23(2):200–205. doi:10.1016/j.semcdb.2011.12.00322202731
   PubMed Web of Science ®Google Scholar
• Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis. 2010;31(3):350–358. doi:10.1093/carcin/bgp18119926638
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang ZJ, Jian WG, et al. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Mol Cancer. 2019;18(1):15. doi:10.1186/s12943-019-0942-130670025
   PubMed Web of Science ®Google Scholar
• Ta HQ, Whitworth H, Yin Y, et al. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth. Mol Cancer. 2019;18(1):113. doi:10.1186/s12943-019-1039-631253147
   PubMed Web of Science ®Google Scholar
• Chen C, Luo Y, He W, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130(1):404–421. doi:10.1172/JCI13089231593555
   PubMed Web of Science ®Google Scholar
• Xiong G, Liu C, Yang G, et al. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer. J Hematol Oncol. 2019;12(1):97. doi:10.1186/s13045-019-0777-731514732
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhao X, Liu Q, et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. Nat Med. 2017;23(11):1331–1341. doi:10.1038/nm.442429035371
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25–30. doi:10.1002/jcp.2505626031493
   PubMed Web of Science ®Google Scholar
• Qin A, Qian W. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression. Int J Mol Med. 2018;42(5):2503–2514. doi:10.3892/ijmm.2018.386430226533
   PubMed Web of Science ®Google Scholar
• Yang W, Yang X, Wang X, et al. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ. J Cell Mol Med. 2019;23(8):4921–4932. doi:10.1111/jcmm.1430531245927
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu J, Huan J, Che F. Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7. Cancer Cell Int. 2020;20:334. doi:10.1186/s12935-020-01421-632714093
   PubMed Web of Science ®Google Scholar
• Klingenberg M, Matsuda A, Diederichs S, Patel T. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603–618. doi:10.1016/j.jhep.2017.04.00928438689
   PubMed Web of Science ®Google Scholar
• McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2020. doi:10.1016/j.semcancer.2020.12.012
   PubMed Web of Science ®Google Scholar
• Li G, Li X, Yuan C, et al. Long non-coding RNA JPX contributes to tumorigenesis by regulating miR-5195-3p/VEGFA in non-small cell lung cancer. Cancer Manag Res. 2021;13:1477–1489. doi:10.2147/CMAR.S25531733613033
   PubMed Web of Science ®Google Scholar
• Liu SL, Cai C, Yang ZY, et al. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway. Int J Biol Sci. 2021;17(2):498–513. doi:10.7150/ijbs.5563633613108
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu B, Liu M, et al. Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP. J Cancer. 2021;12(6):1660–1668. doi:10.7150/jca.4734433613753
   PubMed Web of Science ®Google Scholar
• Bian Z, Zhang J, Li M, et al. LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling. Clin Cancer Res. 2018;24(19):4808–4819. doi:10.1158/1078-0432.CCR-17-296729914894
   PubMed Web of Science ®Google Scholar
• Feng W, Li B, Wang J, et al. Long non-coding RNA LINC00115 contributes to the progression of colorectal cancer by targeting miR-489-3p via the PI3K/AKT/mTOR pathway. Front Genet. 2020;11:567630. doi:10.3389/fgene.2020.56763033193658
   PubMed Web of Science ®Google Scholar
• Giornelli GH. Management of relapsed ovarian cancer: a review. Springerplus. 2016;5(1):1197. doi:10.1186/s40064-016-2660-027516935
   PubMedGoogle Scholar
• Li J, Pan C, Boese AC, et al. DGKA provides platinum resistance in ovarian cancer through activation of c-JUN-WEE1 signaling. Clin Cancer Res. 2020;26(14):3843–3855. doi:10.1158/1078-0432.CCR-19-379032341033
   PubMed Web of Science ®Google Scholar
• Xin L, Liu L, Liu C. DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1. J Cell Physiol. 2020;235(3):2643–2654. doi:10.1002/jcp.2916831517391
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Zheng YP, Dong KS, Dong HH. Effect of microRNA-7 on proliferation, invasion, migration and EMT of hepatoma cell line SMMC-7721. Eur Rev Med Pharmacol Sci. 2020;24(23):12153–12160. doi:10.26355/eurrev_202012_2400433336733
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang S. High-throughput sequencing identification of differentially expressed microRNAs in metastatic ovarian cancer with experimental validations. Cancer Cell Int. 2020;20:517. doi:10.1186/s12935-020-01601-433100909
   PubMed Web of Science ®Google Scholar
• Meng X, Joosse SA, Müller V, et al. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer. 2015;113(9):1358–1366. doi:10.1038/bjc.2015.34026393886
   PubMed Web of Science ®Google Scholar
• Ma Y, Sun Y. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2. Cancer Manag Res. 2019;11:13–23. doi:10.2147/CMAR.S18478130588107
   PubMed Web of Science ®Google Scholar
• Vishnu VV, Muralikrishna B, Verma A, et al. C3G regulates STAT3, ERK, adhesion signaling, and is essential for differentiation of embryonic stem cells. Stem Cell Rev Rep. 2021. doi:10.1007/s12015-021-10136-8
   PubMed Web of Science ®Google Scholar
• Huang X, Yu P, Liu M, et al. ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK/IL-17 signaling pathway. Int Immunopharmacol. 2019;66:236–241. doi:10.1016/j.intimp.2018.11.03130481683
   PubMed Web of Science ®Google Scholar
• Li J, Ye T, Liu Y, et al. Transcriptional activation of Gstp1 by MEK/ERK signaling confers chemo-resistance to cisplatin in lung cancer stem cells. Front Oncol. 2019;9:476. doi:10.3389/fonc.2019.0047631263672
   PubMed Web of Science ®Google Scholar
• Kulshrestha A, Katara GK, Ibrahim SA, et al. Targeting V-ATPase isoform restores cisplatin activity in resistant ovarian cancer: inhibition of autophagy, endosome function, and ERK/MEK pathway. J Oncol. 2019;2019:2343876. doi:10.1155/2019/234387631057611
   PubMed Web of Science ®Google Scholar
• Yu T, Bai W, Su Y, Wang Y, Wang M, Ling C. Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. Exp Mol Pathol. 2020;116:104484. doi:10.1016/j.yexmp.2020.10448432533982
   PubMed Web of Science ®Google Scholar